Squamous Cell Carcinoma of the Paranasal Sinus

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-12-20
Clinical Trial Update: Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating the combination of cetuximab and nivolumab in recurrent or metastatic head and neck squamous cell carcinoma has…